Project
GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for TAL1
Z-value: 1.62
Motif logo
Transcription factors associated with TAL1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
TAL1
|
ENSG00000162367.7 | TAL bHLH transcription factor 1, erythroid differentiation factor |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| TAL1 | hg19_v2_chr1_-_47697387_47697457 | 0.31 | 3.7e-06 | Click! |
Activity profile of TAL1 motif
Sorted Z-values of TAL1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr5_-_42811986 | 57.76 |
ENST00000511224.1
ENST00000507920.1 ENST00000510965.1 |
SEPP1
|
selenoprotein P, plasma, 1 |
| chr11_-_5248294 | 51.88 |
ENST00000335295.4
|
HBB
|
hemoglobin, beta |
| chr17_+_38083977 | 50.16 |
ENST00000578802.1
ENST00000578478.1 ENST00000582263.1 |
RP11-387H17.4
|
RP11-387H17.4 |
| chr22_+_23040274 | 48.19 |
ENST00000390306.2
|
IGLV2-23
|
immunoglobulin lambda variable 2-23 |
| chr7_+_30960915 | 47.43 |
ENST00000441328.2
ENST00000409899.1 ENST00000409611.1 |
AQP1
|
aquaporin 1 (Colton blood group) |
| chr14_+_95078714 | 43.15 |
ENST00000393078.3
ENST00000393080.4 ENST00000467132.1 |
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 |
| chr1_-_182360918 | 42.74 |
ENST00000339526.4
|
GLUL
|
glutamate-ammonia ligase |
| chr17_+_1665345 | 41.44 |
ENST00000576406.1
ENST00000571149.1 |
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
| chr17_+_77681075 | 40.40 |
ENST00000397549.2
|
CTD-2116F7.1
|
CTD-2116F7.1 |
| chr2_-_218808771 | 40.32 |
ENST00000449814.1
ENST00000171887.4 |
TNS1
|
tensin 1 |
| chr19_-_17185848 | 40.32 |
ENST00000593360.1
|
HAUS8
|
HAUS augmin-like complex, subunit 8 |
| chr22_+_22681656 | 38.53 |
ENST00000390291.2
|
IGLV1-50
|
immunoglobulin lambda variable 1-50 (non-functional) |
| chr7_+_150497569 | 38.23 |
ENST00000004103.3
|
TMEM176A
|
transmembrane protein 176A |
| chr22_+_23165153 | 38.09 |
ENST00000390317.2
|
IGLV2-8
|
immunoglobulin lambda variable 2-8 |
| chr8_-_27457494 | 37.53 |
ENST00000521770.1
|
CLU
|
clusterin |
| chr1_-_182360498 | 36.89 |
ENST00000417584.2
|
GLUL
|
glutamate-ammonia ligase |
| chr5_-_42812143 | 36.26 |
ENST00000514985.1
|
SEPP1
|
selenoprotein P, plasma, 1 |
| chr7_+_150497491 | 33.90 |
ENST00000484928.1
|
TMEM176A
|
transmembrane protein 176A |
| chr7_-_150497621 | 33.49 |
ENST00000434545.1
|
TMEM176B
|
transmembrane protein 176B |
| chr3_-_195310802 | 32.62 |
ENST00000421243.1
ENST00000453131.1 |
APOD
|
apolipoprotein D |
| chr6_-_170101749 | 32.18 |
ENST00000448612.1
|
WDR27
|
WD repeat domain 27 |
| chr2_-_86333244 | 31.92 |
ENST00000263857.6
ENST00000409681.1 |
POLR1A
|
polymerase (RNA) I polypeptide A, 194kDa |
| chr3_+_153839149 | 30.89 |
ENST00000465093.1
ENST00000465817.1 |
ARHGEF26
|
Rho guanine nucleotide exchange factor (GEF) 26 |
| chr11_-_62457371 | 30.17 |
ENST00000317449.4
|
LRRN4CL
|
LRRN4 C-terminal like |
| chr4_+_76439665 | 29.83 |
ENST00000508105.1
ENST00000311638.3 ENST00000380837.3 ENST00000507556.1 ENST00000504190.1 ENST00000507885.1 ENST00000502620.1 ENST00000514480.1 |
THAP6
|
THAP domain containing 6 |
| chr22_-_45559642 | 29.57 |
ENST00000426282.2
|
CTA-217C2.1
|
CTA-217C2.1 |
| chr3_+_10206545 | 29.31 |
ENST00000256458.4
|
IRAK2
|
interleukin-1 receptor-associated kinase 2 |
| chr17_+_1665253 | 27.76 |
ENST00000254722.4
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
| chr1_+_153004800 | 27.65 |
ENST00000392661.3
|
SPRR1B
|
small proline-rich protein 1B |
| chr5_+_134240588 | 27.55 |
ENST00000254908.6
|
PCBD2
|
pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1) 2 |
| chr9_+_124088860 | 27.51 |
ENST00000373806.1
|
GSN
|
gelsolin |
| chr22_+_23134974 | 27.49 |
ENST00000390314.2
|
IGLV2-11
|
immunoglobulin lambda variable 2-11 |
| chr19_+_33182823 | 27.04 |
ENST00000397061.3
|
NUDT19
|
nudix (nucleoside diphosphate linked moiety X)-type motif 19 |
| chr3_-_138763734 | 26.85 |
ENST00000413199.1
ENST00000502927.2 |
PRR23C
|
proline rich 23C |
| chr7_+_150498610 | 26.45 |
ENST00000461345.1
|
TMEM176A
|
transmembrane protein 176A |
| chr3_-_196065248 | 26.27 |
ENST00000446879.1
ENST00000273695.3 |
TM4SF19
|
transmembrane 4 L six family member 19 |
| chr1_-_182361327 | 25.91 |
ENST00000331872.6
ENST00000311223.5 |
GLUL
|
glutamate-ammonia ligase |
| chr13_-_88323218 | 25.73 |
ENST00000436290.2
ENST00000453832.2 ENST00000606590.1 |
MIR4500HG
|
MIR4500 host gene (non-protein coding) |
| chr22_+_23248512 | 25.69 |
ENST00000390325.2
|
IGLC3
|
immunoglobulin lambda constant 3 (Kern-Oz+ marker) |
| chr19_-_6690723 | 25.61 |
ENST00000601008.1
|
C3
|
complement component 3 |
| chr14_-_106209368 | 24.57 |
ENST00000390548.2
ENST00000390549.2 ENST00000390542.2 |
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker) |
| chr2_-_89310012 | 24.44 |
ENST00000493819.1
|
IGKV1-9
|
immunoglobulin kappa variable 1-9 |
| chr21_-_46330545 | 24.24 |
ENST00000320216.6
ENST00000397852.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
| chr7_-_150497406 | 24.10 |
ENST00000492607.1
ENST00000326442.5 ENST00000450753.2 |
TMEM176B
|
transmembrane protein 176B |
| chr14_-_106926724 | 23.51 |
ENST00000434710.1
|
IGHV3-43
|
immunoglobulin heavy variable 3-43 |
| chr17_+_1674982 | 23.30 |
ENST00000572048.1
ENST00000573763.1 |
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 |
| chr16_-_55867146 | 23.13 |
ENST00000422046.2
|
CES1
|
carboxylesterase 1 |
| chr2_-_89157161 | 22.88 |
ENST00000390237.2
|
IGKC
|
immunoglobulin kappa constant |
| chr17_-_5138099 | 22.88 |
ENST00000571800.1
ENST00000574081.1 ENST00000399600.4 ENST00000574297.1 |
SCIMP
|
SLP adaptor and CSK interacting membrane protein |
| chr4_-_48018580 | 22.82 |
ENST00000514170.1
|
CNGA1
|
cyclic nucleotide gated channel alpha 1 |
| chr14_-_107078851 | 22.81 |
ENST00000390628.2
|
IGHV1-58
|
immunoglobulin heavy variable 1-58 |
| chr4_+_74718906 | 22.68 |
ENST00000226524.3
|
PF4V1
|
platelet factor 4 variant 1 |
| chr11_+_57365150 | 22.58 |
ENST00000457869.1
ENST00000340687.6 ENST00000378323.4 ENST00000378324.2 ENST00000403558.1 |
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
| chr22_+_23101182 | 22.56 |
ENST00000390312.2
|
IGLV2-14
|
immunoglobulin lambda variable 2-14 |
| chr4_+_175204818 | 22.53 |
ENST00000503780.1
|
CEP44
|
centrosomal protein 44kDa |
| chr17_+_41857793 | 22.38 |
ENST00000449302.3
|
C17orf105
|
chromosome 17 open reading frame 105 |
| chr14_-_106322288 | 22.07 |
ENST00000390559.2
|
IGHM
|
immunoglobulin heavy constant mu |
| chr14_-_100070363 | 21.99 |
ENST00000380243.4
|
CCDC85C
|
coiled-coil domain containing 85C |
| chr9_-_93405352 | 21.89 |
ENST00000375765.3
|
DIRAS2
|
DIRAS family, GTP-binding RAS-like 2 |
| chr14_-_106406090 | 21.88 |
ENST00000390593.2
|
IGHV6-1
|
immunoglobulin heavy variable 6-1 |
| chr18_+_74240610 | 21.66 |
ENST00000578092.1
ENST00000578613.1 ENST00000583578.1 |
LINC00908
|
long intergenic non-protein coding RNA 908 |
| chr11_+_61891445 | 21.55 |
ENST00000394818.3
ENST00000533896.1 ENST00000278849.4 |
INCENP
|
inner centromere protein antigens 135/155kDa |
| chr11_-_111783919 | 21.48 |
ENST00000531198.1
ENST00000533879.1 |
CRYAB
|
crystallin, alpha B |
| chr9_+_139871948 | 21.19 |
ENST00000224167.2
ENST00000457950.1 ENST00000371625.3 ENST00000371623.3 |
PTGDS
|
prostaglandin D2 synthase 21kDa (brain) |
| chr19_-_6720686 | 20.97 |
ENST00000245907.6
|
C3
|
complement component 3 |
| chr4_+_48018781 | 20.83 |
ENST00000295461.5
|
NIPAL1
|
NIPA-like domain containing 1 |
| chr2_+_74120094 | 20.81 |
ENST00000409731.3
ENST00000345517.3 ENST00000409918.1 ENST00000442912.1 ENST00000409624.1 |
ACTG2
|
actin, gamma 2, smooth muscle, enteric |
| chr4_-_17812309 | 20.74 |
ENST00000382247.1
ENST00000536863.1 |
DCAF16
|
DDB1 and CUL4 associated factor 16 |
| chr7_-_99569468 | 20.68 |
ENST00000419575.1
|
AZGP1
|
alpha-2-glycoprotein 1, zinc-binding |
| chr2_+_90139056 | 20.56 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
| chr16_+_1290725 | 20.50 |
ENST00000461509.2
|
TPSAB1
|
tryptase alpha/beta 1 |
| chr11_-_5255696 | 20.45 |
ENST00000292901.3
ENST00000417377.1 |
HBD
|
hemoglobin, delta |
| chr6_+_31554636 | 20.38 |
ENST00000433492.1
|
LST1
|
leukocyte specific transcript 1 |
| chr6_-_159420780 | 20.23 |
ENST00000449822.1
|
RSPH3
|
radial spoke 3 homolog (Chlamydomonas) |
| chr18_-_74728998 | 20.23 |
ENST00000359645.3
ENST00000397875.3 ENST00000397869.3 ENST00000578193.1 ENST00000578873.1 ENST00000397866.4 ENST00000528160.1 ENST00000527041.1 ENST00000526111.1 ENST00000397865.5 ENST00000382582.3 |
MBP
|
myelin basic protein |
| chr4_+_106629929 | 20.21 |
ENST00000512828.1
ENST00000394730.3 ENST00000507281.1 ENST00000515279.1 |
GSTCD
|
glutathione S-transferase, C-terminal domain containing |
| chr5_-_1295104 | 20.18 |
ENST00000334602.6
ENST00000508104.2 ENST00000310581.5 ENST00000296820.5 |
TERT
|
telomerase reverse transcriptase |
| chr3_-_167813672 | 20.11 |
ENST00000470487.1
|
GOLIM4
|
golgi integral membrane protein 4 |
| chr15_+_90777424 | 20.05 |
ENST00000561433.1
ENST00000559204.1 ENST00000558291.1 |
GDPGP1
|
GDP-D-glucose phosphorylase 1 |
| chr14_-_107131560 | 20.04 |
ENST00000390632.2
|
IGHV3-66
|
immunoglobulin heavy variable 3-66 |
| chr14_-_21270995 | 19.93 |
ENST00000555698.1
ENST00000397970.4 ENST00000340900.3 |
RNASE1
|
ribonuclease, RNase A family, 1 (pancreatic) |
| chr2_-_85555086 | 19.93 |
ENST00000444342.2
ENST00000409232.3 ENST00000409015.1 |
TGOLN2
|
trans-golgi network protein 2 |
| chr19_+_18208603 | 19.79 |
ENST00000262811.6
|
MAST3
|
microtubule associated serine/threonine kinase 3 |
| chr14_-_107219365 | 19.65 |
ENST00000424969.2
|
IGHV3-74
|
immunoglobulin heavy variable 3-74 |
| chr12_-_54982300 | 19.64 |
ENST00000547431.1
|
PPP1R1A
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A |
| chr14_-_21270561 | 19.59 |
ENST00000412779.2
|
RNASE1
|
ribonuclease, RNase A family, 1 (pancreatic) |
| chr3_-_122134882 | 19.44 |
ENST00000330689.4
|
WDR5B
|
WD repeat domain 5B |
| chr9_+_91933726 | 19.42 |
ENST00000534113.2
|
SECISBP2
|
SECIS binding protein 2 |
| chr9_-_34710066 | 19.37 |
ENST00000378792.1
ENST00000259607.2 |
CCL21
|
chemokine (C-C motif) ligand 21 |
| chr5_+_170288856 | 19.34 |
ENST00000523189.1
|
RANBP17
|
RAN binding protein 17 |
| chr2_+_89999259 | 19.23 |
ENST00000558026.1
|
IGKV2D-28
|
immunoglobulin kappa variable 2D-28 |
| chr14_-_106781017 | 19.22 |
ENST00000390612.2
|
IGHV4-28
|
immunoglobulin heavy variable 4-28 |
| chrX_+_55478538 | 19.17 |
ENST00000342972.1
|
MAGEH1
|
melanoma antigen family H, 1 |
| chr14_-_106539557 | 19.03 |
ENST00000390599.2
|
IGHV1-8
|
immunoglobulin heavy variable 1-8 |
| chr7_-_150038704 | 18.98 |
ENST00000466675.1
ENST00000482669.1 ENST00000467793.1 ENST00000223271.3 |
RARRES2
|
retinoic acid receptor responder (tazarotene induced) 2 |
| chr11_+_1874200 | 18.94 |
ENST00000311604.3
|
LSP1
|
lymphocyte-specific protein 1 |
| chr12_-_11548496 | 18.88 |
ENST00000389362.4
ENST00000565533.1 ENST00000546254.1 |
PRB2
PRB1
|
proline-rich protein BstNI subfamily 2 proline-rich protein BstNI subfamily 1 |
| chr18_+_21693306 | 18.82 |
ENST00000540918.2
|
TTC39C
|
tetratricopeptide repeat domain 39C |
| chrX_+_46937745 | 18.79 |
ENST00000397180.1
ENST00000457380.1 ENST00000352078.4 |
RGN
|
regucalcin |
| chr6_+_123110302 | 18.76 |
ENST00000368440.4
|
SMPDL3A
|
sphingomyelin phosphodiesterase, acid-like 3A |
| chr1_+_220960033 | 18.60 |
ENST00000366910.5
|
MARC1
|
mitochondrial amidoxime reducing component 1 |
| chr3_+_167453493 | 18.51 |
ENST00000295777.5
ENST00000472747.2 |
SERPINI1
|
serpin peptidase inhibitor, clade I (neuroserpin), member 1 |
| chr16_+_1290694 | 18.45 |
ENST00000338844.3
|
TPSAB1
|
tryptase alpha/beta 1 |
| chr17_-_41465674 | 18.44 |
ENST00000592135.1
ENST00000587874.1 ENST00000588654.1 ENST00000592094.1 |
LINC00910
|
long intergenic non-protein coding RNA 910 |
| chr6_+_123110465 | 18.31 |
ENST00000539041.1
|
SMPDL3A
|
sphingomyelin phosphodiesterase, acid-like 3A |
| chr10_+_106034884 | 18.31 |
ENST00000369707.2
ENST00000429569.2 |
GSTO2
|
glutathione S-transferase omega 2 |
| chr16_-_3306587 | 18.26 |
ENST00000541159.1
ENST00000536379.1 ENST00000219596.1 ENST00000339854.4 |
MEFV
|
Mediterranean fever |
| chr4_-_168155169 | 18.20 |
ENST00000534949.1
ENST00000535728.1 |
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
| chr10_-_105452917 | 17.97 |
ENST00000427662.2
|
SH3PXD2A
|
SH3 and PX domains 2A |
| chr19_+_57831829 | 17.95 |
ENST00000321545.4
|
ZNF543
|
zinc finger protein 543 |
| chr16_-_55866997 | 17.87 |
ENST00000360526.3
ENST00000361503.4 |
CES1
|
carboxylesterase 1 |
| chr12_-_91574142 | 17.81 |
ENST00000547937.1
|
DCN
|
decorin |
| chr6_-_33048483 | 17.79 |
ENST00000419277.1
|
HLA-DPA1
|
major histocompatibility complex, class II, DP alpha 1 |
| chr19_+_8478154 | 17.71 |
ENST00000381035.4
ENST00000595142.1 ENST00000601724.1 ENST00000393944.1 ENST00000215555.2 ENST00000601283.1 ENST00000595213.1 |
MARCH2
|
membrane-associated ring finger (C3HC4) 2, E3 ubiquitin protein ligase |
| chr12_+_130554803 | 17.68 |
ENST00000535487.1
|
RP11-474D1.2
|
RP11-474D1.2 |
| chr19_+_45409011 | 17.63 |
ENST00000252486.4
ENST00000446996.1 ENST00000434152.1 |
APOE
|
apolipoprotein E |
| chr7_-_150498426 | 17.51 |
ENST00000447204.2
|
TMEM176B
|
transmembrane protein 176B |
| chr7_+_150498783 | 17.51 |
ENST00000475536.1
ENST00000468689.1 |
TMEM176A
|
transmembrane protein 176A |
| chr14_+_102027688 | 17.48 |
ENST00000510508.4
ENST00000359323.3 |
DIO3
|
deiodinase, iodothyronine, type III |
| chr19_-_33793430 | 17.34 |
ENST00000498907.2
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha |
| chr1_-_20306909 | 17.33 |
ENST00000375111.3
ENST00000400520.3 |
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid) |
| chr2_+_95691417 | 17.23 |
ENST00000309988.4
|
MAL
|
mal, T-cell differentiation protein |
| chr8_-_120685608 | 17.22 |
ENST00000427067.2
|
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2 |
| chr20_+_34043085 | 17.09 |
ENST00000397527.1
ENST00000342580.4 |
CEP250
|
centrosomal protein 250kDa |
| chr16_+_84209539 | 17.08 |
ENST00000569735.1
|
DNAAF1
|
dynein, axonemal, assembly factor 1 |
| chr12_+_57146233 | 17.04 |
ENST00000554643.1
ENST00000556650.1 ENST00000554150.1 ENST00000554155.1 |
HSD17B6
|
hydroxysteroid (17-beta) dehydrogenase 6 |
| chrX_-_107018969 | 16.99 |
ENST00000372383.4
|
TSC22D3
|
TSC22 domain family, member 3 |
| chr7_-_158622210 | 16.99 |
ENST00000251527.5
|
ESYT2
|
extended synaptotagmin-like protein 2 |
| chr22_+_23264766 | 16.94 |
ENST00000390331.2
|
IGLC7
|
immunoglobulin lambda constant 7 |
| chr4_+_156587979 | 16.85 |
ENST00000511507.1
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
| chr22_+_23247030 | 16.75 |
ENST00000390324.2
|
IGLJ3
|
immunoglobulin lambda joining 3 |
| chr19_+_35521572 | 16.71 |
ENST00000262631.5
|
SCN1B
|
sodium channel, voltage-gated, type I, beta subunit |
| chr16_-_1843720 | 16.57 |
ENST00000415638.3
ENST00000215539.3 |
IGFALS
|
insulin-like growth factor binding protein, acid labile subunit |
| chr14_+_73704201 | 16.54 |
ENST00000340738.5
ENST00000427855.1 ENST00000381166.3 |
PAPLN
|
papilin, proteoglycan-like sulfated glycoprotein |
| chr20_+_55904815 | 16.38 |
ENST00000371263.3
ENST00000345868.4 ENST00000371260.4 ENST00000418127.1 |
SPO11
|
SPO11 meiotic protein covalently bound to DSB |
| chr11_-_66725837 | 16.35 |
ENST00000393958.2
ENST00000393960.1 ENST00000524491.1 ENST00000355677.3 |
PC
|
pyruvate carboxylase |
| chr11_+_124492749 | 16.30 |
ENST00000531667.1
ENST00000441174.3 ENST00000375005.4 |
TBRG1
|
transforming growth factor beta regulator 1 |
| chr19_+_18794470 | 16.17 |
ENST00000321949.8
ENST00000338797.6 |
CRTC1
|
CREB regulated transcription coactivator 1 |
| chr19_-_51531272 | 16.16 |
ENST00000319720.7
|
KLK11
|
kallikrein-related peptidase 11 |
| chr10_-_90712520 | 16.10 |
ENST00000224784.6
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta |
| chr8_+_134125727 | 16.09 |
ENST00000521107.1
|
TG
|
thyroglobulin |
| chr5_-_139944196 | 16.06 |
ENST00000357560.4
|
APBB3
|
amyloid beta (A4) precursor protein-binding, family B, member 3 |
| chr1_+_24882560 | 16.04 |
ENST00000374392.2
|
NCMAP
|
noncompact myelin associated protein |
| chr16_-_33647696 | 16.03 |
ENST00000558425.1
ENST00000569103.2 |
RP11-812E19.9
|
Uncharacterized protein |
| chr4_-_168155300 | 16.00 |
ENST00000541637.1
|
SPOCK3
|
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 3 |
| chr4_+_75858318 | 15.99 |
ENST00000307428.7
|
PARM1
|
prostate androgen-regulated mucin-like protein 1 |
| chr19_+_5681011 | 15.92 |
ENST00000581893.1
ENST00000411793.2 ENST00000301382.4 ENST00000581773.1 ENST00000423665.2 ENST00000583928.1 ENST00000342970.2 ENST00000422535.2 ENST00000581521.1 ENST00000339423.2 |
HSD11B1L
|
hydroxysteroid (11-beta) dehydrogenase 1-like |
| chr1_+_13910194 | 15.90 |
ENST00000376057.4
ENST00000510906.1 |
PDPN
|
podoplanin |
| chr4_-_57522598 | 15.81 |
ENST00000553379.2
|
HOPX
|
HOP homeobox |
| chr20_-_35492048 | 15.81 |
ENST00000237536.4
|
SOGA1
|
suppressor of glucose, autophagy associated 1 |
| chr18_+_39766626 | 15.80 |
ENST00000593234.1
ENST00000585627.1 ENST00000591199.1 ENST00000586990.1 ENST00000593051.1 ENST00000593316.1 ENST00000591381.1 ENST00000585639.1 ENST00000589068.1 |
LINC00907
|
long intergenic non-protein coding RNA 907 |
| chr11_-_111781454 | 15.79 |
ENST00000533280.1
|
CRYAB
|
crystallin, alpha B |
| chr14_-_94856987 | 15.70 |
ENST00000449399.3
ENST00000404814.4 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
| chr20_-_524362 | 15.70 |
ENST00000460062.2
ENST00000608066.1 |
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide |
| chr4_-_681114 | 15.64 |
ENST00000503156.1
|
MFSD7
|
major facilitator superfamily domain containing 7 |
| chr20_-_18774614 | 15.63 |
ENST00000412553.1
|
LINC00652
|
long intergenic non-protein coding RNA 652 |
| chr10_-_48438974 | 15.59 |
ENST00000224605.2
|
GDF10
|
growth differentiation factor 10 |
| chr4_-_87374283 | 15.54 |
ENST00000361569.2
|
MAPK10
|
mitogen-activated protein kinase 10 |
| chr11_-_117747434 | 15.52 |
ENST00000529335.2
ENST00000530956.1 ENST00000260282.4 |
FXYD6
|
FXYD domain containing ion transport regulator 6 |
| chr22_-_27620603 | 15.47 |
ENST00000418271.1
ENST00000444114.1 |
RP5-1172A22.1
|
RP5-1172A22.1 |
| chr4_-_57522673 | 15.47 |
ENST00000381255.3
ENST00000317745.7 ENST00000555760.2 ENST00000556614.2 |
HOPX
|
HOP homeobox |
| chr22_+_23241661 | 15.39 |
ENST00000390322.2
|
IGLJ2
|
immunoglobulin lambda joining 2 |
| chr1_-_15735925 | 15.39 |
ENST00000427824.1
|
RP3-467K16.4
|
RP3-467K16.4 |
| chr14_-_106967788 | 15.38 |
ENST00000390622.2
|
IGHV1-46
|
immunoglobulin heavy variable 1-46 |
| chr11_-_111781610 | 15.37 |
ENST00000525823.1
|
CRYAB
|
crystallin, alpha B |
| chr11_+_2421718 | 15.33 |
ENST00000380996.5
ENST00000333256.6 ENST00000380992.1 ENST00000437110.1 ENST00000435795.1 |
TSSC4
|
tumor suppressing subtransferable candidate 4 |
| chr22_+_23243156 | 15.32 |
ENST00000390323.2
|
IGLC2
|
immunoglobulin lambda constant 2 (Kern-Oz- marker) |
| chr11_-_5255861 | 15.28 |
ENST00000380299.3
|
HBD
|
hemoglobin, delta |
| chr4_+_156588115 | 15.25 |
ENST00000455639.2
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
| chr19_-_36643329 | 15.25 |
ENST00000589154.1
|
COX7A1
|
cytochrome c oxidase subunit VIIa polypeptide 1 (muscle) |
| chr19_-_11669960 | 15.19 |
ENST00000589171.1
ENST00000590700.1 ENST00000586683.1 ENST00000593077.1 ENST00000252445.3 |
ELOF1
|
elongation factor 1 homolog (S. cerevisiae) |
| chr14_-_94856951 | 15.13 |
ENST00000553327.1
ENST00000556955.1 ENST00000557118.1 ENST00000440909.1 |
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
| chr19_-_57183114 | 15.11 |
ENST00000537055.2
ENST00000601659.1 |
ZNF835
|
zinc finger protein 835 |
| chr16_-_30032610 | 15.06 |
ENST00000574405.1
|
DOC2A
|
double C2-like domains, alpha |
| chr1_-_47407111 | 15.00 |
ENST00000371904.4
|
CYP4A11
|
cytochrome P450, family 4, subfamily A, polypeptide 11 |
| chr11_-_117698765 | 14.96 |
ENST00000532119.1
|
FXYD2
|
FXYD domain containing ion transport regulator 2 |
| chr12_+_69201923 | 14.93 |
ENST00000462284.1
ENST00000258149.5 ENST00000356290.4 ENST00000540827.1 ENST00000428863.2 ENST00000393412.3 |
MDM2
|
MDM2 oncogene, E3 ubiquitin protein ligase |
| chr14_+_22446680 | 14.87 |
ENST00000390443.3
|
TRAV8-6
|
T cell receptor alpha variable 8-6 |
| chr1_+_169337172 | 14.82 |
ENST00000367807.3
ENST00000367808.3 ENST00000329281.2 ENST00000420531.1 |
BLZF1
|
basic leucine zipper nuclear factor 1 |
| chr17_+_48610074 | 14.79 |
ENST00000503690.1
ENST00000514874.1 ENST00000537145.1 ENST00000541226.1 |
EPN3
|
epsin 3 |
| chr2_+_90108504 | 14.71 |
ENST00000390271.2
|
IGKV6D-41
|
immunoglobulin kappa variable 6D-41 (non-functional) |
| chr1_-_40237020 | 14.70 |
ENST00000327582.5
|
OXCT2
|
3-oxoacid CoA transferase 2 |
| chr2_+_189839046 | 14.69 |
ENST00000304636.3
ENST00000317840.5 |
COL3A1
|
collagen, type III, alpha 1 |
| chr2_+_95691445 | 14.67 |
ENST00000353004.3
ENST00000354078.3 ENST00000349807.3 |
MAL
|
mal, T-cell differentiation protein |
| chr19_+_2977444 | 14.65 |
ENST00000246112.4
ENST00000453329.1 ENST00000482627.1 ENST00000452088.1 |
TLE6
|
transducin-like enhancer of split 6 (E(sp1) homolog, Drosophila) |
| chr11_-_114466477 | 14.63 |
ENST00000375478.3
|
NXPE4
|
neurexophilin and PC-esterase domain family, member 4 |
| chr11_-_117747607 | 14.62 |
ENST00000540359.1
ENST00000539526.1 |
FXYD6
|
FXYD domain containing ion transport regulator 6 |
| chr3_+_40566369 | 14.60 |
ENST00000403205.2
ENST00000310898.1 ENST00000339296.5 ENST00000431278.1 |
ZNF621
|
zinc finger protein 621 |
| chr15_-_49338624 | 14.60 |
ENST00000261847.3
ENST00000380927.2 ENST00000559424.1 |
SECISBP2L
|
SECIS binding protein 2-like |
| chr17_-_26695013 | 14.59 |
ENST00000555059.2
|
CTB-96E2.2
|
Homeobox protein SEBOX |
| chr15_+_75118888 | 14.55 |
ENST00000395018.4
|
CPLX3
|
complexin 3 |
| chr17_-_42402138 | 14.49 |
ENST00000592857.1
ENST00000586016.1 ENST00000590194.1 ENST00000377095.5 ENST00000588049.1 ENST00000586633.1 ENST00000537904.2 ENST00000585636.1 ENST00000585523.1 ENST00000225308.8 |
SLC25A39
|
solute carrier family 25, member 39 |
| chr19_+_57742431 | 14.46 |
ENST00000302804.7
|
AURKC
|
aurora kinase C |
| chr15_+_66874502 | 14.46 |
ENST00000558797.1
|
RP11-321F6.1
|
HCG2003567; Uncharacterized protein |
| chr20_+_57267669 | 14.45 |
ENST00000356091.6
|
NPEPL1
|
aminopeptidase-like 1 |
| chr1_-_161277210 | 14.44 |
ENST00000491222.2
|
MPZ
|
myelin protein zero |
| chr6_-_32908765 | 14.41 |
ENST00000416244.2
|
HLA-DMB
|
major histocompatibility complex, class II, DM beta |
| chr1_-_11866034 | 14.36 |
ENST00000376590.3
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H) |
| chr5_-_149535421 | 14.34 |
ENST00000261799.4
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide |
| chr9_+_139873264 | 14.32 |
ENST00000446677.1
|
PTGDS
|
prostaglandin D2 synthase 21kDa (brain) |
Network of associatons between targets according to the STRING database.
First level regulatory network of TAL1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 26.6 | 106.3 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 24.0 | 96.2 | GO:0030185 | nitric oxide transport(GO:0030185) |
| 19.8 | 98.8 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
| 15.5 | 46.6 | GO:0002894 | positive regulation of type IIa hypersensitivity(GO:0001798) positive regulation of type II hypersensitivity(GO:0002894) |
| 14.7 | 206.4 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 13.0 | 52.1 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
| 12.0 | 72.2 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 11.1 | 66.8 | GO:0061518 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 10.3 | 31.0 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 10.3 | 10.3 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 10.0 | 30.0 | GO:1900159 | iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) positive regulation of bone mineralization involved in bone maturation(GO:1900159) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
| 9.3 | 27.9 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 9.2 | 27.6 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
| 9.1 | 90.9 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 9.0 | 27.1 | GO:2001190 | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001190) |
| 8.6 | 8.6 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 8.4 | 25.2 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 8.3 | 8.3 | GO:0046755 | viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
| 7.6 | 22.9 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 7.6 | 37.9 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
| 7.5 | 22.5 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 7.5 | 30.0 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
| 7.5 | 37.3 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 7.4 | 22.2 | GO:1902995 | regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
| 7.3 | 14.6 | GO:0001300 | chronological cell aging(GO:0001300) |
| 7.1 | 21.4 | GO:1903413 | cellular response to bile acid(GO:1903413) |
| 7.0 | 42.1 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 7.0 | 7.0 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
| 6.8 | 27.2 | GO:0003095 | pressure natriuresis(GO:0003095) |
| 6.8 | 27.2 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 6.5 | 13.1 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
| 6.5 | 6.5 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 6.5 | 19.4 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
| 6.4 | 19.2 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 6.4 | 31.9 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 6.3 | 25.1 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 6.3 | 18.8 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
| 6.2 | 18.7 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 6.1 | 18.4 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 6.1 | 24.4 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
| 6.1 | 18.3 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 6.1 | 861.0 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 6.0 | 18.1 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 5.9 | 17.8 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 5.9 | 23.7 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 5.8 | 17.5 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 5.6 | 22.5 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
| 5.6 | 22.2 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
| 5.5 | 16.5 | GO:0042361 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 5.4 | 16.2 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 5.4 | 10.8 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 5.4 | 16.2 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
| 5.4 | 5.4 | GO:0032609 | interferon-gamma production(GO:0032609) |
| 5.3 | 16.0 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
| 5.3 | 21.2 | GO:1902022 | lysine transport(GO:0015819) L-lysine transport(GO:1902022) |
| 5.2 | 5.2 | GO:1902224 | cellular ketone body metabolic process(GO:0046950) ketone body biosynthetic process(GO:0046951) ketone body metabolic process(GO:1902224) |
| 5.2 | 15.6 | GO:0002582 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 5.2 | 15.5 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
| 5.1 | 20.6 | GO:2000768 | positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
| 5.0 | 15.0 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
| 5.0 | 24.8 | GO:0035106 | operant conditioning(GO:0035106) |
| 5.0 | 19.9 | GO:0032811 | negative regulation of epinephrine secretion(GO:0032811) |
| 4.9 | 14.7 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 4.9 | 29.4 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
| 4.9 | 24.4 | GO:1901731 | positive regulation of platelet aggregation(GO:1901731) |
| 4.8 | 19.3 | GO:0060023 | soft palate development(GO:0060023) |
| 4.8 | 14.3 | GO:0072276 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
| 4.8 | 4.8 | GO:0014719 | regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014717) positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) skeletal muscle satellite cell activation(GO:0014719) satellite cell activation involved in skeletal muscle regeneration(GO:0014901) |
| 4.8 | 14.3 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
| 4.7 | 14.1 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 4.7 | 18.8 | GO:1904640 | response to methionine(GO:1904640) |
| 4.6 | 32.5 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 4.6 | 9.2 | GO:0032526 | response to retinoic acid(GO:0032526) |
| 4.6 | 9.2 | GO:0046113 | nucleobase catabolic process(GO:0046113) |
| 4.6 | 13.7 | GO:1904317 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 4.5 | 22.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 4.5 | 13.4 | GO:0019732 | antifungal humoral response(GO:0019732) |
| 4.5 | 22.3 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 4.4 | 44.5 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
| 4.4 | 13.2 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 4.4 | 17.6 | GO:0006710 | androgen catabolic process(GO:0006710) |
| 4.4 | 4.4 | GO:0045937 | positive regulation of phosphorus metabolic process(GO:0010562) positive regulation of phosphate metabolic process(GO:0045937) |
| 4.3 | 4.3 | GO:0051255 | spindle midzone assembly(GO:0051255) |
| 4.3 | 13.0 | GO:0010193 | response to ozone(GO:0010193) |
| 4.3 | 4.3 | GO:0035456 | response to interferon-beta(GO:0035456) |
| 4.3 | 21.3 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
| 4.3 | 4.3 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 4.2 | 12.7 | GO:0051946 | regulation of amino acid import(GO:0010958) regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
| 4.2 | 88.8 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 4.2 | 46.1 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 4.2 | 12.5 | GO:0070105 | positive regulation of interleukin-6-mediated signaling pathway(GO:0070105) |
| 4.1 | 8.3 | GO:0036100 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 4.1 | 16.6 | GO:0007525 | somatic muscle development(GO:0007525) |
| 4.1 | 16.5 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
| 4.1 | 20.6 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 4.1 | 8.2 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
| 4.0 | 20.2 | GO:1904207 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 4.0 | 12.0 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 3.9 | 11.8 | GO:1904395 | retinal rod cell differentiation(GO:0060221) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) negative regulation of neuromuscular junction development(GO:1904397) |
| 3.9 | 11.7 | GO:1900073 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 3.9 | 19.5 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 3.9 | 31.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
| 3.9 | 7.8 | GO:1902263 | apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 3.9 | 11.6 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 3.8 | 11.4 | GO:0097359 | UDP-glucosylation(GO:0097359) |
| 3.8 | 22.8 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
| 3.8 | 11.3 | GO:0015670 | carbon dioxide transport(GO:0015670) |
| 3.8 | 11.3 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
| 3.7 | 7.5 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
| 3.7 | 11.1 | GO:0060398 | regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 3.7 | 22.2 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
| 3.7 | 7.4 | GO:0070781 | response to biotin(GO:0070781) |
| 3.7 | 7.4 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
| 3.7 | 7.3 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
| 3.6 | 65.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 3.6 | 14.5 | GO:0006072 | glycerol-3-phosphate metabolic process(GO:0006072) |
| 3.6 | 18.0 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
| 3.6 | 43.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 3.6 | 10.7 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
| 3.6 | 10.7 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 3.5 | 17.7 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) |
| 3.5 | 17.6 | GO:0071350 | interleukin-15-mediated signaling pathway(GO:0035723) cellular response to interleukin-15(GO:0071350) |
| 3.5 | 10.5 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
| 3.5 | 21.0 | GO:0001554 | luteolysis(GO:0001554) |
| 3.5 | 10.5 | GO:0035284 | rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 3.5 | 3.5 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 3.5 | 73.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 3.5 | 17.3 | GO:2001293 | malonyl-CoA metabolic process(GO:2001293) |
| 3.5 | 17.3 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 3.4 | 34.5 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
| 3.4 | 16.9 | GO:0072023 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
| 3.4 | 3.4 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 3.4 | 6.7 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 3.3 | 3.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 3.3 | 3.3 | GO:1904062 | regulation of cation transmembrane transport(GO:1904062) |
| 3.3 | 6.6 | GO:0005985 | sucrose metabolic process(GO:0005985) |
| 3.3 | 3.3 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
| 3.3 | 9.8 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
| 3.3 | 3.3 | GO:0014900 | muscle hyperplasia(GO:0014900) |
| 3.3 | 45.6 | GO:0015671 | oxygen transport(GO:0015671) |
| 3.3 | 26.0 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 3.2 | 13.0 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
| 3.2 | 6.5 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
| 3.2 | 3.2 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
| 3.2 | 9.7 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 3.2 | 9.7 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
| 3.2 | 19.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 3.2 | 12.8 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 3.2 | 9.5 | GO:0090291 | negative regulation of osteoclast proliferation(GO:0090291) |
| 3.1 | 9.4 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 3.1 | 18.7 | GO:0010269 | response to selenium ion(GO:0010269) |
| 3.1 | 6.2 | GO:0051414 | response to cortisol(GO:0051414) |
| 3.0 | 6.1 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 3.0 | 18.2 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
| 3.0 | 27.2 | GO:0015747 | urate transport(GO:0015747) |
| 3.0 | 33.1 | GO:0000050 | urea cycle(GO:0000050) |
| 3.0 | 24.0 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 3.0 | 9.0 | GO:0001207 | histone displacement(GO:0001207) regulation of transcription involved in meiotic cell cycle(GO:0051037) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
| 3.0 | 6.0 | GO:1901162 | primary amino compound biosynthetic process(GO:1901162) |
| 3.0 | 35.8 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 3.0 | 20.9 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 3.0 | 8.9 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
| 3.0 | 26.6 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) |
| 2.9 | 5.9 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
| 2.9 | 11.7 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 2.9 | 5.8 | GO:0060621 | regulation of cholesterol import(GO:0060620) negative regulation of cholesterol import(GO:0060621) regulation of sterol import(GO:2000909) negative regulation of sterol import(GO:2000910) |
| 2.9 | 8.7 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
| 2.9 | 5.8 | GO:0002215 | defense response to nematode(GO:0002215) |
| 2.9 | 11.6 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 2.9 | 8.6 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
| 2.9 | 11.5 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 2.9 | 42.9 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
| 2.9 | 2.9 | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
| 2.8 | 8.5 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
| 2.8 | 8.5 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
| 2.8 | 2.8 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 2.8 | 8.5 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 2.8 | 11.3 | GO:0033076 | isoquinoline alkaloid metabolic process(GO:0033076) |
| 2.8 | 5.6 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 2.8 | 11.2 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 2.8 | 5.6 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
| 2.8 | 5.5 | GO:1904747 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 2.8 | 11.1 | GO:1902617 | response to fluoride(GO:1902617) |
| 2.8 | 5.5 | GO:0046601 | positive regulation of centriole replication(GO:0046601) |
| 2.8 | 8.3 | GO:0032571 | response to vitamin K(GO:0032571) |
| 2.8 | 2.8 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
| 2.7 | 11.0 | GO:0035624 | receptor transactivation(GO:0035624) |
| 2.7 | 13.7 | GO:0009407 | toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
| 2.7 | 8.2 | GO:0002384 | hepatic immune response(GO:0002384) |
| 2.7 | 19.1 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 2.7 | 2.7 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 2.7 | 8.1 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 2.7 | 51.2 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 2.7 | 10.8 | GO:0010650 | positive regulation of cell communication by electrical coupling(GO:0010650) maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 2.7 | 13.5 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 2.7 | 24.1 | GO:0015705 | iodide transport(GO:0015705) |
| 2.7 | 18.7 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
| 2.7 | 10.6 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 2.7 | 47.8 | GO:0036376 | sodium ion export from cell(GO:0036376) |
| 2.6 | 2.6 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
| 2.6 | 21.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 2.6 | 26.3 | GO:0060174 | limb bud formation(GO:0060174) |
| 2.6 | 10.5 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 2.6 | 10.4 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 2.6 | 7.8 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 2.6 | 7.7 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
| 2.6 | 2.6 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
| 2.6 | 17.9 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 2.5 | 7.6 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 2.5 | 7.6 | GO:0071529 | cementum mineralization(GO:0071529) |
| 2.5 | 7.6 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 2.5 | 10.2 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 2.5 | 10.1 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
| 2.5 | 42.7 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
| 2.5 | 17.6 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
| 2.5 | 15.0 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 2.5 | 12.5 | GO:0019532 | oxalate transport(GO:0019532) |
| 2.5 | 2.5 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 2.5 | 7.4 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 2.5 | 7.4 | GO:0035607 | fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development(GO:0035607) |
| 2.5 | 51.5 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
| 2.4 | 9.8 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 2.4 | 21.9 | GO:0043406 | positive regulation of MAP kinase activity(GO:0043406) |
| 2.4 | 24.2 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
| 2.4 | 2.4 | GO:0031133 | regulation of axon diameter(GO:0031133) |
| 2.4 | 36.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
| 2.4 | 7.2 | GO:0072248 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 2.4 | 9.5 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
| 2.4 | 2.4 | GO:0042220 | response to cocaine(GO:0042220) |
| 2.4 | 7.1 | GO:1900114 | positive regulation of histone H3-K9 trimethylation(GO:1900114) |
| 2.4 | 11.9 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 2.4 | 40.3 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
| 2.4 | 7.1 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 2.4 | 7.1 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
| 2.3 | 4.7 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
| 2.3 | 11.7 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 2.3 | 7.0 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 2.3 | 23.4 | GO:0051610 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 2.3 | 7.0 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
| 2.3 | 16.2 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 2.3 | 4.6 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
| 2.3 | 16.1 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
| 2.3 | 9.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
| 2.3 | 16.0 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
| 2.3 | 11.3 | GO:1903564 | regulation of protein localization to cilium(GO:1903564) |
| 2.3 | 61.0 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 2.3 | 38.3 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 2.3 | 6.8 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
| 2.2 | 15.7 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 2.2 | 4.5 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
| 2.2 | 8.9 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
| 2.2 | 11.2 | GO:0035524 | proline transmembrane transport(GO:0035524) |
| 2.2 | 11.2 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 2.2 | 24.5 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 2.2 | 13.4 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
| 2.2 | 6.7 | GO:0002818 | intracellular defense response(GO:0002818) |
| 2.2 | 20.0 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
| 2.2 | 6.7 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 2.2 | 8.9 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 2.2 | 8.8 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 2.2 | 13.3 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 2.2 | 6.6 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 2.2 | 11.0 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 2.2 | 11.0 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
| 2.2 | 54.7 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 2.2 | 6.5 | GO:0071503 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
| 2.1 | 8.5 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 2.1 | 17.1 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
| 2.1 | 6.4 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
| 2.1 | 6.4 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 2.1 | 2.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
| 2.1 | 77.7 | GO:0018149 | peptide cross-linking(GO:0018149) |
| 2.1 | 4.2 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
| 2.1 | 6.3 | GO:1904430 | negative regulation of t-circle formation(GO:1904430) |
| 2.1 | 10.5 | GO:1901091 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
| 2.1 | 12.6 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 2.1 | 4.2 | GO:2000366 | regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
| 2.1 | 12.4 | GO:0030820 | regulation of cyclic nucleotide catabolic process(GO:0030805) regulation of cAMP catabolic process(GO:0030820) regulation of purine nucleotide catabolic process(GO:0033121) |
| 2.1 | 10.4 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
| 2.1 | 10.3 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 2.1 | 8.2 | GO:0015811 | L-cystine transport(GO:0015811) |
| 2.1 | 4.1 | GO:1903115 | regulation of actin filament-based movement(GO:1903115) |
| 2.0 | 16.4 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 2.0 | 4.1 | GO:0036269 | swimming behavior(GO:0036269) |
| 2.0 | 14.3 | GO:0002933 | lipid hydroxylation(GO:0002933) |
| 2.0 | 14.3 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 2.0 | 6.1 | GO:0070672 | response to interleukin-15(GO:0070672) |
| 2.0 | 14.2 | GO:0070862 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 2.0 | 8.1 | GO:1905176 | response to mycophenolic acid(GO:0071505) cellular response to mycophenolic acid(GO:0071506) metanephric glomerular mesangial cell development(GO:0072255) reversible differentiation(GO:0090677) cell dedifferentiation involved in phenotypic switching(GO:0090678) positive regulation of phenotypic switching(GO:1900241) regulation of vascular smooth muscle cell dedifferentiation(GO:1905174) positive regulation of vascular smooth muscle cell dedifferentiation(GO:1905176) vascular smooth muscle cell dedifferentiation(GO:1990936) |
| 2.0 | 4.1 | GO:1901534 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
| 2.0 | 6.0 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
| 2.0 | 8.0 | GO:0003335 | corneocyte development(GO:0003335) |
| 2.0 | 14.0 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
| 2.0 | 7.9 | GO:0071226 | response to molecule of fungal origin(GO:0002238) cellular response to molecule of fungal origin(GO:0071226) |
| 2.0 | 4.0 | GO:0050942 | positive regulation of pigment cell differentiation(GO:0050942) |
| 2.0 | 2.0 | GO:0035963 | cellular response to interleukin-13(GO:0035963) |
| 2.0 | 15.6 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 2.0 | 5.9 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 2.0 | 3.9 | GO:0045124 | regulation of bone resorption(GO:0045124) |
| 2.0 | 5.9 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
| 1.9 | 3.9 | GO:0030828 | positive regulation of cGMP metabolic process(GO:0030825) positive regulation of cGMP biosynthetic process(GO:0030828) |
| 1.9 | 7.7 | GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
| 1.9 | 5.8 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
| 1.9 | 9.6 | GO:0030916 | otic vesicle formation(GO:0030916) |
| 1.9 | 30.6 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 1.9 | 13.3 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
| 1.9 | 5.7 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 1.9 | 5.7 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
| 1.9 | 9.4 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
| 1.9 | 30.1 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
| 1.9 | 3.8 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) |
| 1.9 | 7.5 | GO:0021633 | optic nerve structural organization(GO:0021633) |
| 1.9 | 11.3 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 1.9 | 7.5 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 1.9 | 1.9 | GO:1990403 | embryonic brain development(GO:1990403) |
| 1.9 | 5.6 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 1.9 | 7.5 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
| 1.9 | 20.5 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 1.9 | 9.3 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 1.9 | 5.6 | GO:0018874 | benzoate metabolic process(GO:0018874) butyrate metabolic process(GO:0019605) |
| 1.8 | 12.9 | GO:0045007 | depurination(GO:0045007) |
| 1.8 | 24.0 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
| 1.8 | 3.7 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 1.8 | 9.2 | GO:1904383 | response to sodium phosphate(GO:1904383) |
| 1.8 | 1.8 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
| 1.8 | 9.2 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 1.8 | 12.8 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
| 1.8 | 5.5 | GO:0090034 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
| 1.8 | 3.7 | GO:0070092 | glucagon secretion(GO:0070091) regulation of glucagon secretion(GO:0070092) |
| 1.8 | 9.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
| 1.8 | 7.3 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 1.8 | 3.6 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 1.8 | 18.1 | GO:0006069 | ethanol oxidation(GO:0006069) |
| 1.8 | 3.6 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
| 1.8 | 18.0 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 1.8 | 3.6 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
| 1.8 | 7.2 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
| 1.8 | 7.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 1.8 | 8.9 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 1.8 | 14.2 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 1.8 | 21.3 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
| 1.8 | 3.5 | GO:0072300 | positive regulation of metanephric glomerulus development(GO:0072300) |
| 1.8 | 5.3 | GO:0002590 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 1.7 | 8.7 | GO:0045991 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite activation of transcription(GO:0045991) |
| 1.7 | 8.7 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
| 1.7 | 5.2 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 1.7 | 5.2 | GO:0036309 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
| 1.7 | 39.6 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
| 1.7 | 5.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 1.7 | 5.2 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
| 1.7 | 8.6 | GO:1902731 | negative regulation of chondrocyte proliferation(GO:1902731) |
| 1.7 | 1.7 | GO:0070988 | demethylation(GO:0070988) |
| 1.7 | 10.2 | GO:0017121 | phospholipid scrambling(GO:0017121) |
| 1.7 | 3.4 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
| 1.7 | 5.1 | GO:0006864 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 1.7 | 6.8 | GO:0032096 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 1.7 | 13.5 | GO:0060073 | micturition(GO:0060073) |
| 1.7 | 11.7 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
| 1.7 | 16.7 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 1.7 | 10.0 | GO:0044241 | lipid digestion(GO:0044241) |
| 1.7 | 8.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 1.7 | 18.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
| 1.7 | 8.3 | GO:0042737 | drug catabolic process(GO:0042737) |
| 1.6 | 19.8 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
| 1.6 | 27.9 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 1.6 | 14.8 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 1.6 | 24.6 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 1.6 | 3.3 | GO:0022900 | electron transport chain(GO:0022900) |
| 1.6 | 8.2 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
| 1.6 | 6.5 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
| 1.6 | 4.9 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 1.6 | 3.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 1.6 | 6.5 | GO:0032342 | aldosterone metabolic process(GO:0032341) aldosterone biosynthetic process(GO:0032342) cortisol metabolic process(GO:0034650) cortisol biosynthetic process(GO:0034651) |
| 1.6 | 1.6 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
| 1.6 | 9.7 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
| 1.6 | 4.8 | GO:0044804 | nucleophagy(GO:0044804) |
| 1.6 | 12.9 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 1.6 | 4.8 | GO:2000439 | monocyte extravasation(GO:0035696) regulation of monocyte extravasation(GO:2000437) positive regulation of monocyte extravasation(GO:2000439) |
| 1.6 | 6.4 | GO:2000170 | negative regulation of gap junction assembly(GO:1903597) positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 1.6 | 1.6 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
| 1.6 | 3.2 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
| 1.6 | 3.2 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
| 1.6 | 3.2 | GO:0002331 | pre-B cell differentiation(GO:0002329) pre-B cell allelic exclusion(GO:0002331) |
| 1.6 | 4.8 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
| 1.6 | 16.0 | GO:0001825 | blastocyst formation(GO:0001825) |
| 1.6 | 1.6 | GO:0018377 | protein myristoylation(GO:0018377) |
| 1.6 | 26.9 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 1.6 | 6.2 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 1.6 | 9.3 | GO:0001781 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) |
| 1.5 | 9.3 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 1.5 | 6.2 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
| 1.5 | 1.5 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
| 1.5 |